MARIA ASTRA FECUNDO: Open Payments
NPI 1457681835 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 25 payments from 10 companies in 2025. Trend: 2023 $778 · 2024 $712 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 12 | $157 |
| Ardelyx, Inc. | 1 | $110 |
| Calliditas Therapeutics US Inc. | 2 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Amgen Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Travere Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $19 |
Products named: VELPHORO, XPHOZAH 30 MG, TARPEYO, Fabhalta, FARXIGA, Ozempic, JARDIANCE, KRYSTEXXA.
Industry payments across IA — which companies pay providers there.
